ArticleBMJ open respiratory research2026
Association between tuberculosis diagnosis delay and respiratory health and well-being among tuberculosis survivors in Cambodia: a prospective cohort study.
Article in BMJ open respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough tuberculosis (TB) treatment success rates are high globally, growing evidence indicates that many TB survivors experience persistent respiratory symptoms, impaired quality of life and reduced well-being after treatment completion. Delayed TB diagnosis may exacerbate these long-term consequences by prolonging untreated disease and lung injury. However, longitudinal evidence linking diagnosis delay to longer-term outcomes remains limited. This study examines the association between TB diagnosis delay and respiratory health, quality of life and mental health among TB survivors in Cambodia.
methodsA prospective cohort study of adults with newly diagnosed TB was conducted with a baseline in 2022 and 1 year and 2 year follow-ups. TB diagnosis delay was defined as the time from symptom onset to diagnosis and categorised as short or long using the median (64 days). Outcome variables included respiratory health, quality of life and depressive symptoms, assessed with the St George's Respiratory Questionnaire for Chronic Obstructive Pulmonary Disease (SGRQ-C), WHO Quality of Life-Brief (WHOQOL-BREF) and Centre for Epidemiologic Studies Depression Scale, 10-item version (CES-D-10), respectively. Linear mixed-effects models, adjusted for potential confounders, were applied.
resultsAmong 712 participants at baseline, the long-delay group had worse respiratory health before treatment completion and over 2 years, with higher SGRQ-C total (β=4.37, 95% CI 1.10 to 7.64), symptom (β=5.83, 95% CI 2.34 to 9.31) and activity scores (β=6.95, 95% CI 2.67 to 11.23) than the short-delay group. Long delay was also associated with poorer psychological (β=-3.17, 95% CI -5.31 to -1.03) and environmental domains (β=-1.74, 95% CI -3.07 to -0.4) of the quality of life but not with its physical and social domains or depressive symptoms. The differences between the groups remained relatively stable over time.
conclusionsTB diagnosis delay may influence recovery beyond treatment success, highlighting the importance of early case detection and integrated post-treatment support in high-burden settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.